Pharmacological Options for the Treatment of Tourette’s Disorder

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2165/00003495-200161150-00005PMID 11772131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Treatment of hyperkinetic movement disorders.

  2009cited by this paper
• Novel Use of Tramadol Hydrochloride in the Treatment of Tourette ’ s Syndrome

  2009cited by this paper
• Gilles de la Tourette Syndrome: symptomatic treatment based on evidence

  2009cited by this paper
• Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride

  2004cited by this paper
• Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

  2003cited by this paper
• Lamotrigine‐Induced Tic Disorder: Report of Five Pediatric Cases

  2000cited by this paper
• Macrocephaly--cutis marmorata telangiectatica congenita: report of five patients and a review of the literature.

  2000cited by this paper
• Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

  2000cited by this paper
• Botulinum toxin in the treatment of tics.

  2000cited by this paper
• [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].

  2000cited by this paper
• Progressive response to Botulinum A toxin in cerebral palsy

  2000cited by this paper
• Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide

  2000cited by this paper
• Progressive response to botulinum A toxin in cerebral palsy.

  2000cited by this paper
• Pharmacologic treatment of tic disorders.

  2000cited by this paper
• Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.

  2000cited by this paper
• Effective open‐label treatment of Tourette's disorder with olanzapine

  2000cited by this paper
• Tourette’s syndrome improvement with pergolide in a randomized, double-blind, crossover trial

  2000cited by this paper
• Tics in Tourette Syndrome: New Treatment Options

  1999cited by this paper
• Ondansetron treatment in patients with Tourette's syndrome.

  1999cited by this paper
• Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol.

  1999cited by this paper
• The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome

  1999cited by this paper
• Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

  1999cited by this paper
• Stimulants and tic disorders: from dogma to data.

  1999cited by this paper
• Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

  1999cited by this paper
• Neurosurgery for Obsessive-Compulsive Disorder: Problems With Comorbidity

  1999cited by this paper
• Short-term versus longer term pimozide therapy in Tourette’s syndrome: A preliminary study

  1999cited by this paper
• Ketanserin treatment of Tourette's syndrome in children.

  1999cited by this paper
• Cyproterone acetate treatment of Tourette's syndrome.

  1999cited by this paper
• Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus

  1999cited by this paper
• Citalopram and fluvoxamine in Tourette's disorder.

  1999cited by this paper
• Lamotrigine-induced tourettism

  1999cited by this paper
• Cannabinoids: possible role in patho‐physiology and therapy of Gilles de la Tourette syndrome

  1998cited by this paper
• Response of major depression and Tourette's syndrome to ECT: a case report.

  1998cited by this paper
• Clozapine in Tourette's syndrome.

  1998cited by this paper
• Treatment of Tourette's syndrome with mecamylamine.

  1998cited by this paper
• Relaxation therapy in Tourette syndrome: a pilot study.

  1998cited by this paper
• Vocal tics in gilles de la tourette syndrome treated with botulinum toxin injections

  1998cited by this paper
• A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.

  1998cited by this paper
• Olanzapine in Tourette syndrome

  1998cited by this paper
• Gilles de la Tourette-Syndrom Einfluß von Nikotin, Alkohol und Marihuana auf die klinische Symptomatik

  1997cited by this paper
• Seignot's paper on the treatment of Tourette's syndrome with haloperidol*

  1997cited by this paper
• Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome.

  1997cited by this paper
• [Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms].

  1997cited by this paper
• Long-term effects of tetrabenazine in hyperkinetic movement disorders

  1997cited by this paper
• Fluoxetine Has No Marked Effect on Tic Symptoms in Patients with Tourette's Syndrome: A Double-Blind Placebo-Controlled Study

  1997cited by this paper
• Immunoglobulintherapie bei Gilles-de-la-Tourette-Syndrom

  1997cited by this paper
• Future therapies of Tourette syndrome.

  1997cited by this paper
• Nicardipine improves motor tics

  1997cited by this paper
• Attention deficit hyperactivity disorder in the presence of Tourette syndrome.

  1997cited by this paper
• Transient, paroxysmal, shock-like paresthesias associated with paroxetine initiation.

  1997cited by this paper
• Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

  1997cited by this paper
• TREATMENT OF TICS

  1997cited by this paper
• Tourette syndrome. Treatment of tics.

  1997cited by this paper
• Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.

  1997cited by this paper
• Epidemiology of Tourette syndrome.

  1997cited by this paper
• Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study

  1997cited by this paper
• Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide

  1997cited by this paper
• Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum.

  1997cited by this paper
• [Immunoglobulin therapy in Gilles de la Tourette syndrome].

  1997cited by this paper
• Cognitive-behavioral therapy and treatment for late-life depression.

  1996cited by this paper
• A Brazilian cohort of patients with Tourette's syndrome.

  1996cited by this paper
• Sequential application of major habit-reversal components to treat motor tics in children.

  1996cited by this paper
• 156 cases of Gilles de la Tourette's syndrome treated by acupuncture.

  1996cited by this paper
• A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder

  1996cited by this paper
• Gilles de la Tourette and the discovery of Tourette syndrome. Includes a translation of his 1884 article.

  1996cited by this paper
• Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance.

  1996cited by this paper
• Botulinum toxin for refractory vocal tics

  1996cited by this paper
• Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.

  1996cited by this paper
• Risperidone as a treatment for Tourette's syndrome.

  1996cited by this paper
• Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome

  1996cited by this paper
• The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience.

  1996cited by this paper
• A brief behavior therapy protocol for Tourette syndrome.

  1996cited by this paper
• Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome.

  1996cited by this paper
• Case study: comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder.

  1996cited by this paper
• Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences

  1996cited by this paper
• Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree.

  1996cited by this paper
• Muscle control in chronic tic disorders

  1995cited by this paper
• Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

  1995influential reference
• Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism.

  1995cited by this paper
• Sertraline‐induced exacerbation of Tics in Tourette's syndrome

  1995cited by this paper
• Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

  1995cited by this paper
• Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.

  1995cited by this paper
• School Observations of Children with Attention‐Deficit Hyperactivity Disorder and Comorbid Tic Disorder: Effects of Methylphenidate Treatment

  1995cited by this paper
• Longitudinal evolution of prefrontal leucotomy in Tourett's syndrome

  1995cited by this paper
• Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.

  1995cited by this paper
• Neurosurgical treatment of Tourette's syndrome: a critical review.

  1995cited by this paper
• The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

  1995cited by this paper
• Treatment of a vocal tic by differential reinforcement.

  1995cited by this paper
• Buspirone treatment of Tourette's syndrome.

  1995cited by this paper
• Risperidone in Gilles de la Tourette syndrome

  1995cited by this paper
• Effects of calcium antagonists on the dopamine system.

  1995cited by this paper
• Competing responses for the treatment of Tourette syndrome and tic disorders.

  1995cited by this paper
• Prolonged erection associated with risperidone treatment.

  1995cited by this paper
• Botulinum toxin in the treatment of dystonic tics

  1994cited by this paper
• Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder

  1994cited by this paper
• Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial.

  1994cited by this paper
• Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome.

  1994cited by this paper
• Steroid hormones and Tourette's syndrome: early experience with antiandrogen therapy.

  1994cited by this paper
• Risperidone for Tourette's syndrome.

  1994cited by this paper

• The α6 GABAA Receptor Positive Allosteric Modulator DK-I-56-1 Reduces Tic-Related Behaviors in Mouse Models of Tourette Syndrome

  2021cites this paper
• Tics and Tourette syndrome

  2021cites this paper
• Tics and Tourette Syndrome.

  2019cites this paper
• A Systematic Review of Psychological and Pharmacological Interventions for the Management of Trichotillomania in Children and Adolescents

  2019cites this paper
• Tourette syndrome increases risk of bone fractures: a population-based cohort study

  2017cites this paper
• The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders

  2017cites this paper
• Outpatient Treatment of Tic Disorders Among Children and Adults

  2017cites this paper
• Outpatient Treatment Patterns of Pediatric Obsessive-Compulsive Disorder

  2017cites this paper
• Prevalence of Movement Disorders in Pediatric Age Group.

  2016cites this paper
• The D1CT‐7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement

  2016cites this paper
• Fragile X syndrome: A review of clinical management.

  2016cites this paper
• Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon

  2015cites this paper
• Trastornos del movimiento (IV): otros trastornos del movimiento

  2015cites this paper
• School Psychologists' Training and Knowledge of Tourette Syndrome

  2015cites this paper
• Animal models of tic disorders: a translational perspective.

  2014cites this paper
• Trials of Pharmacological Interventions for Tourette Syndrome: A Systematic Review

  2013cites this paper
• Pharmacological animal models of tic disorders.

  2013cites this paper
• Malignant Phonic Tics

  2013cites this paper
• Common Movement Disorders in Children: Diagnosis, Pathogenesis and Management

  2012cites this paper
• Olanzapine treatment for tics in an adult woman with severe tourette syndrome.

  2012cites this paper
• Catecholamine-related gene expression in blood correlates with tic severity in tourette syndrome.

  2012cites this paper
• Síndrome de Gilles de La Tourette: Clínica, diagnóstico e abordagem terapêutica

  2012cites this paper
• Tics and tourette syndrome

  2011cites this paper
• Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders

  2011cites this paper
• Chapter 16 – Tics and Tourette syndrome

  2011cites this paper
• Immunologic analysis and serum heavy metal levels in exacerbated Tourette syndrome

  2010cites this paper
• Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.

  2010cites this paper
• Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.

  2010cites this paper
• Aripiprazole for the Treatment of Adolescent Tourette’s Syndrome

  2010cites this paper
• Individual differences in the inhibition of stimulus-stimulus and stimulus-response associations and medication effects on associative learning in Tourette syndrome and ADHD

  2010cites this paper
• Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents.

  2010cites this paper
• SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner.

  2009cites this paper
• Trichotillomania: neurobiology and treatment.

  2009cites this paper
• Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract

  2009cites this paper
• [Therapeutic use of tetrabenazine].

  2009cites this paper
• Neurosurgical strategies for Gilles de la Tourette’s syndrome

  2008cites this paper
• Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders

  2007cites this paper
• Neuropsychiatric consequences of cardiovascular medications

  2007cites this paper
• Tetrabenazine in the treatment of Huntington’s disease

  2007cites this paper
• Anwendungsgebiete neuerer Antipsychotika in der Behandlung von Kindern und Jugendlichen außerhalb des schizophrenen Spektrums

  2006cites this paper
• Tetrabenazine in the treatment of hyperkinetic movement disorders

  2006cites this paper
• Anesthetic management for cesarean delivery in a woman with Gilles de la Tourette's syndrome.

  2006cites this paper
• Obesity and ADHD may represent different manifestations of a common environmental oversampling syndrome: a model for revealing mechanistic overlap among cognitive, metabolic, and inflammatory disorders.

  2006cites this paper
• The role of the extrapersonal brain systems in religious activity.

  2006cites this paper
• Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.

  2005cites this paper
• Olanzapine in Gilles de la Tourette syndrome: beyond tics.

  2005cites this paper
• Tic disorders: from pathophysiology to treatment

  2005cites this paper
• Emerging drugs in Tourette syndrome

  2005cites this paper
• Atypical antipsychotics in the treatment of children and adolescents: clinical applications.

  2004cites this paper
• Case study: severe self-injurious behavior in comorbid Tourette's disorder and OCD.

  2004cites this paper
• Tetrabenazine Treatment in Movement Disorders

  2004cites this paper
• Case Studies in Movement Disorders

  2003cites this paper
• [Gilles de la tourette syndrome: clinical spectrum and management].

  2003cites this paper
• Meta‐analysis of the association between the catecholamine‐O‐methyl‐transferase gene and obsessive‐compulsive disorder

  2003cites this paper